News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,630 Results
Type
Article (3175)
Company Profile (98)
Press Release (156356)
Section
Business (47568)
Career Advice (93)
Deals (8443)
Drug Delivery (3)
Drug Development (29374)
Employer Resources (12)
FDA (2393)
Job Trends (3218)
News (86555)
Policy (5639)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (151)
Accelerated approval (4)
Adcomms (5)
Allergies (43)
Alliances (10758)
ALS (55)
Alzheimer's disease (375)
Antibody-drug conjugate (ADC) (93)
Approvals (2585)
Artificial intelligence (84)
Autoimmune disease (53)
Automation (4)
Bankruptcy (49)
Best Places to Work (2848)
BIOSECURE Act (2)
Biosimilars (73)
Biotechnology (65)
Bladder cancer (36)
Brain cancer (15)
Breast cancer (141)
Cancer (1336)
Cardiovascular disease (84)
Career advice (86)
Career pathing (2)
CAR-T (86)
CDC (1)
Cell therapy (170)
Cervical cancer (6)
Clinical research (26660)
Collaboration (450)
Compensation (618)
Complete response letters (9)
COVID-19 (396)
CRISPR (15)
C-suite (293)
Cystic fibrosis (32)
Data (2112)
Depression (48)
Diabetes (107)
Diagnostics (339)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (44)
Drug pricing (10)
Drug shortages (1)
Duchenne muscular dystrophy (41)
Earnings (22497)
Editorial (3)
Employer branding (1)
Employer resources (11)
Events (33211)
Executive appointments (340)
FDA (3282)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (313)
Gene editing (30)
Generative AI (6)
Gene therapy (69)
GLP-1 (191)
Government (397)
Grass and pollen (1)
Guidances (120)
Healthcare (1736)
HIV (18)
Huntington's disease (7)
IgA nephropathy (17)
Immunology and inflammation (43)
Immuno-oncology (16)
Indications (38)
Infectious disease (440)
Inflammatory bowel disease (54)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (68)
Interviews (13)
IPO (5273)
IRA (3)
Job creations (509)
Job search strategy (77)
JPM (2)
Kidney cancer (8)
Layoffs (33)
Leadership (2)
Legal (700)
Liver cancer (20)
Longevity (2)
Lung cancer (230)
Lymphoma (120)
Machine learning (9)
Management (4)
Manufacturing (200)
MASH (87)
Medical device (304)
Medtech (304)
Mergers & acquisitions (3544)
Metabolic disorders (309)
Multiple sclerosis (58)
NASH (7)
Neurodegenerative disease (59)
Neuropsychiatric disorders (22)
Neuroscience (745)
NextGen: Class of 2026 (705)
Non-profit (186)
Now hiring (4)
Obesity (110)
Opinion (20)
Ovarian cancer (42)
Pain (47)
Pancreatic cancer (50)
Parkinson's disease (67)
Patents (117)
Patient recruitment (169)
Peanut (18)
People (15558)
Pharmaceutical (30)
Pharmacy benefit managers (1)
Phase 1 (7847)
Phase 2 (12110)
Phase 3 (8803)
Pipeline (1740)
Policy (13)
Postmarket research (478)
Preclinical (2886)
Press Release (11)
Prostate cancer (57)
Psychedelics (12)
Radiopharmaceuticals (97)
Rare diseases (202)
Real estate (945)
Recruiting (7)
Regulatory (5647)
Reports (8)
Research institute (205)
Resumes & cover letters (6)
RSV (13)
Schizophrenia (91)
Series A (45)
Series B (36)
Service/supplier (1)
Sickle cell disease (18)
Spinal muscular atrophy (42)
Sponsored (1)
Startups (719)
State (1)
Supply chain (15)
Tariffs (7)
Vaccines (137)
Venture capital (5)
Weight loss (23)
Women's health (9)
Date
Last 7 days (154)
Last 30 days (550)
Last 365 days (9320)
2026 (835)
2025 (9427)
2024 (10757)
2023 (12376)
2022 (14249)
2021 (16016)
2020 (13734)
2019 (8861)
2018 (6260)
2017 (8083)
2016 (6583)
2015 (8401)
2014 (6331)
2013 (4529)
2012 (4458)
2011 (4457)
2010 (4477)
Location
Africa (88)
Alabama (15)
Arizona (26)
Arkansas (2)
Asia (12333)
Australia (1380)
California (3870)
Canada (727)
China (632)
Colorado (109)
Connecticut (158)
Delaware (175)
Europe (22537)
Florida (532)
Georgia (122)
Idaho (4)
Illinois (173)
India (15)
Indiana (111)
Iowa (9)
Japan (108)
Kansas (67)
Kentucky (10)
Maine (2)
Maryland (356)
Massachusetts (2960)
Michigan (40)
Minnesota (121)
Mississippi (1)
Missouri (20)
Montana (1)
Nebraska (5)
Nevada (11)
New Hampshire (4)
New Jersey (1267)
New Mexico (4)
New York (1241)
North Carolina (475)
Northern California (2084)
Ohio (97)
Oklahoma (5)
Oregon (10)
Pennsylvania (637)
Puerto Rico (2)
Rhode Island (4)
South America (127)
South Carolina (5)
Southern California (1476)
Tennessee (14)
Texas (397)
United States (13112)
Utah (65)
Virginia (83)
Washington D.C. (15)
Washington State (223)
Wisconsin (16)
159,630 Results for "mapp biopharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
DCN Dx and Mapp Biopharmaceutical Announce Subcontract
DCN Dx announced a subcontract with Mapp Biopharmaceutical, Inc., a developer of novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
February 1, 2023
·
3 min read
Bio NC
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment.
January 23, 2023
·
3 min read
Press Releases
Angitia Biopharmaceuticals Announces $130 Million Series D Financing
February 5, 2026
·
4 min read
Press Releases
Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors
February 2, 2026
·
3 min read
Business
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, signed an exclusive term sheet to secure international development and global commercial rights upon licensure for the pan-Ebola and pan-Marburg monoclonal antibody (mAbs) programs from Mapp Biopharmaceutical, Inc.
December 5, 2022
·
9 min read
Drug Development
MAPS PBC Announces Publication of Results from Confirmatory Phase 3 “MAPP2" Trial of MDMA-Assisted Therapy for PTSD in Nature Medicine
MAPS Public Benefit Corporation (“MAPS PBC”) announced that data from the company’s MAPP2 clinical trial, a multi-site Phase 3 study of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”), was published in the September issue of Nature Medicine.
September 14, 2023
·
11 min read
Press Releases
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
November 13, 2025
·
10 min read
Press Releases
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
January 8, 2026
·
2 min read
Press Releases
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
February 2, 2026
·
3 min read
Press Releases
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
January 14, 2026
·
5 min read
1 of 15,963
Next
